Doctor profile · Federal record
Dr. David Korman, MD
Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Denver, CO
- NPI 1245297555
- Accepts Medicare
- MIPS 88.3 / 100 · 2023
- 33 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4500 E 9Th Ave, 500 S
Denver, CO 80220
(303) 861-2190
fax (303) 355-4435
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Colorado #36976 · Kansas #0428878
- Medicaid
- CO #01369768
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1245297555. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,649
Distinct HCPCS
10
Medicare allowed
$198,392
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 4,500 | 48 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 467 | 227 | $124 | |
J3489 |
Injection, zoledronic acid, 1 mg | 165 | 33 | $9 | |
96372 |
Injection of drug or substance under skin or into muscle | 145 | 59 | $15 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 88 | 44 | $67 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 62 | 13 | $29 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 59 | 59 | $168 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 56 | 14 | $135 | |
77080 |
Dxa bone density measurement of hip, pelvis, spine | 31 | 31 | $40 | |
77085 |
Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 19 | 19 | $55 |
In context: peer comparison
Among 19 peers in this city , average services per provider: 2,043. This provider delivers 2.8× the peer median.Open Payments
Industry payments received
All-time total
$2,544
Transactions
130
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 17 | $283.47 | |
| PFIZER INC. | 18 | $230.78 | |
| UCB, Inc. | 12 | $226.42 | |
| AstraZeneca Pharmaceuticals LP | 10 | $212.21 | |
| ABBVIE INC. | 10 | $186.71 | |
| Novartis Pharmaceuticals Corporation | 10 | $158.05 | |
| Aurinia Pharma U.S., Inc. | 11 | $153.65 | |
| SOBI, INC | 8 | $145.54 | |
| Lilly USA, LLC | 5 | $136.04 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $134.23 | |
| GlaxoSmithKline, LLC. | 6 | $120.99 | |
| Radius Health, Inc. | 4 | $71.86 | |
| Alexion Pharmaceuticals, Inc. | 3 | $70.40 | |
| Genentech USA, Inc. | 3 | $54.22 | |
| Sandoz Inc. | 2 | $48.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,625
Patients
434
Total drug cost
$47,182
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 319 | 98 | $4,122 |
| Hydroxychloroquine Sulfate | Generic | 260 | 70 | $18,275 |
| Methotrexate (Methotrexate Sodium) | Brand | 210 | 55 | $9,232 |
| Celecoxib | Generic | 136 | 37 | $2,805 |
| Duloxetine Hcl | Generic | 119 | 25 | $2,120 |
| Alendronate Sodium | Generic | 81 | 17 | $927 |
| Folic Acid | Generic | 74 | 19 | $364 |
| Leflunomide | Generic | 65 | 22 | $3,285 |
| Methylprednisolone | Generic | 60 | 20 | $1,434 |
| Allopurinol | Generic | 55 | 14 | $986 |
Frequently asked questions
What is Dr. David Korman's medical specialty?
Dr. David Korman practices Rheumatology Physician in Denver, CO.
Where does Dr. David Korman practice?
Dr. David Korman practices at 4500 E 9Th Ave, Denver, CO 80220. Office phone: 3038612190.
What is Dr. David Korman's NPI?
Dr. David Korman's National Provider Identifier (NPI) is 1245297555, issued by NPPES.
Does Dr. David Korman accept Medicare assignment?
Yes. Dr. David Korman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Korman commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Injection, zoledronic acid, 1 mg (HCPCS J3489). Source: CMS Medicare Physician & Other Practitioners file.